Alterity Therapeutics's total assets for Q2 2026 were AU$56.92M, an increase of 23.67% from the previous quarter. PRNAF total liabilities were AU$2.65M for the fiscal quarter, a -26.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.